Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
All India
Product Description
Mitoxantrone Injection USP is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Mitoxantrone is classified as an "antitumor antibiotic."
Mitoxantrone Is Used For :
Advanced prostate cancer not responding to hormone treatment - used in combination with steroids.
Acute myelogenous leukemia (AML)
Breast cancer
Non-Hodgkin's lymphoma
The following side effects are common (occurring in greater than 30%) for patients taking Mitoxantrone:
Low blood counts. Your white and red blood cells and platelets may temporarily decrease. This can put you at increased risk for infection, anemia and/or bleeding. Increases in blood tests measuring liver function. These return to normal once treatment is discontinued.